Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are maintaining our Neutral recommendation on The Valspar Corporation (VAL - Analyst Report) following our assessment of its mixed fourth-quarter fiscal 2012 results. Adjusted earnings of 86 cents beat the Zacks Consensus Estimate by a penny. Sales edged down roughly 2% year over year to $1.02 billion and missed the Zacks Consensus Estimate of $1.08 billion.
Valspar, the sixth largest paint and coatings manufacturer globally, continues to see strength in its coatings business as evidenced by higher volumes, new business wins and market share gains. While the company expects the overall demand environment to be uneven moving ahead, it envisions a double-digit growth in earnings in fiscal 2013.
Valspar, which competes with Sherwin Williams Company (SHW - Analyst Report) and PPG Industries Inc. (PPG - Analyst Report), has a strong pipeline of new products and significant opportunities for share gains in both its Paint and Coatings segments. The company should also benefit from its restructuring actions in fiscal 2013.
Valspar expects sales to benefit from the diverse mix of businesses and growth in the fast growing coatings markets in Asia and Latin America. The company is managing its cost well and maintaining a cost structure that is appropriate for the current external environment.
Winning new businesses also remain a company-wide focus that will position Valspar well for the future and help offset lower demand in core markets. Its fastest growing markets are the emerging economies.
However, Valspar’s Paint segment had a weak fourth quarter. The segment’s growth has been hurt by a weak residential housing market in Australia, which may continue to affect sales moving ahead.
We also remain concerned about cost pressures associated with raw material inflation. Raw material costs have been volatile and Valspar has experienced disruptions in supplies of certain raw materials at various times, impacting its ability to manufacture products.
Our recommendation on the stock is in agreement with a short-term Zacks #3 Rank (Hold).
Get the full Analyst Report on PPG - FREE
Get the full Analyst Report on VAL - FREE
Get the full Analyst Report on SHW - FREE